Structure

Physi-Chem Properties

Molecular Weight:  696.42
Volume:  741.486
LogP:  4.467
LogD:  3.044
LogS:  -4.447
# Rotatable Bonds:  2
TPSA:  147.43
# H-Bond Aceptor:  9
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.168
Synthetic Accessibility Score:  6.996
Fsp3:  0.707
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.871
MDCK Permeability:  1.4871268831484485e-05
Pgp-inhibitor:  0.979
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.946
20% Bioavailability (F20%):  0.157
30% Bioavailability (F30%):  0.45

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.953
Plasma Protein Binding (PPB):  87.77445220947266%
Volume Distribution (VD):  1.498
Pgp-substrate:  5.450246334075928%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.126
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.743
CYP2C9-inhibitor:  0.017
CYP2C9-substrate:  0.02
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.062
CYP3A4-inhibitor:  0.849
CYP3A4-substrate:  0.518

ADMET: Excretion

Clearance (CL):  14.531
Half-life (T1/2):  0.143

ADMET: Toxicity

hERG Blockers:  0.009
Human Hepatotoxicity (H-HT):  0.17
Drug-inuced Liver Injury (DILI):  0.111
AMES Toxicity:  0.038
Rat Oral Acute Toxicity:  0.546
Maximum Recommended Daily Dose:  0.923
Skin Sensitization:  0.617
Carcinogencity:  0.913
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.989

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC101067

Natural Product ID:  NPC101067
Common Name*:   Bisglaucumlide G
IUPAC Name:   n.a.
Synonyms:   Bisglaucumlide G
Standard InCHIKey:  APYCNDHUMQUETQ-DXFSNFGHSA-N
Standard InCHI:  InChI=1S/C41H60O9/c1-23(2)28-20-32(42)26(5)12-10-11-24(3)18-33(43)31-19-27(6)29-21-36(46)40(8,48)37-15-16-39(7,50-37)35(45)14-13-25(4)17-30(29)41(31,22-34(28)44)38(47)49-9/h12,17-18,23,28,30-31,35-37,45-46,48H,10-11,13-16,19-22H2,1-9H3/b24-18+,25-17+,26-12+/t28-,30-,31+,35-,36-,37+,39-,40-,41-/m0/s1
SMILES:  CC(C)[C@@H]1CC(=O)/C(=C/CC/C(=C/C(=O)[C@H]2CC(=C3C[C@@H]([C@@](C)([C@H]4CC[C@@](C)([C@H](CC/C(=C/[C@@H]3[C@]2(CC1=O)C(=O)OC)/C)O)O4)O)O)C)/C)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL564585
PubChem CID:   44140534
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0000357] Sesquaterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22820 Sarcophyton glaucum Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[15332846]
NPO22820 Sarcophyton glaucum Species Alcyoniidae Eukaryota n.a. Amami Oshima, Kagoshima Prefecture, Japan n.a. PMID[16933862]
NPO22820 Sarcophyton glaucum Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[19331379]
NPO22820 Sarcophyton glaucum Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[21563811]
NPO22820 Sarcophyton glaucum Species Alcyoniidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 = 58000.0 nM PMID[554462]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC101067 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC476134
0.9479 High Similarity NPC476235
0.9479 High Similarity NPC476126
0.9375 High Similarity NPC476213
0.9375 High Similarity NPC477870
0.9375 High Similarity NPC476246
0.9375 High Similarity NPC477871
0.9062 High Similarity NPC124246
0.8889 High Similarity NPC283567
0.88 High Similarity NPC475321
0.8529 High Similarity NPC470104
0.8173 Intermediate Similarity NPC255309
0.8137 Intermediate Similarity NPC167974
0.8131 Intermediate Similarity NPC286880
0.8131 Intermediate Similarity NPC5284
0.8095 Intermediate Similarity NPC96377
0.8095 Intermediate Similarity NPC471332
0.8095 Intermediate Similarity NPC471333
0.8095 Intermediate Similarity NPC102352
0.8077 Intermediate Similarity NPC69171
0.8077 Intermediate Similarity NPC474165
0.8061 Intermediate Similarity NPC478003
0.8061 Intermediate Similarity NPC478004
0.8061 Intermediate Similarity NPC158388
0.8041 Intermediate Similarity NPC309656
0.8039 Intermediate Similarity NPC471331
0.8039 Intermediate Similarity NPC99657
0.8039 Intermediate Similarity NPC203388
0.8039 Intermediate Similarity NPC471330
0.8039 Intermediate Similarity NPC222303
0.8039 Intermediate Similarity NPC472687
0.8037 Intermediate Similarity NPC153239
0.802 Intermediate Similarity NPC8803
0.8 Intermediate Similarity NPC114162
0.8 Intermediate Similarity NPC146731
0.8 Intermediate Similarity NPC296950
0.8 Intermediate Similarity NPC469819
0.8 Intermediate Similarity NPC472756
0.7981 Intermediate Similarity NPC183571
0.7981 Intermediate Similarity NPC473163
0.7963 Intermediate Similarity NPC5103
0.7961 Intermediate Similarity NPC472727
0.7961 Intermediate Similarity NPC472728
0.7946 Intermediate Similarity NPC234522
0.7944 Intermediate Similarity NPC19412
0.7944 Intermediate Similarity NPC154608
0.7944 Intermediate Similarity NPC277017
0.7944 Intermediate Similarity NPC192813
0.7941 Intermediate Similarity NPC27105
0.7928 Intermediate Similarity NPC40632
0.7928 Intermediate Similarity NPC251236
0.7928 Intermediate Similarity NPC328374
0.7928 Intermediate Similarity NPC96312
0.7909 Intermediate Similarity NPC469463
0.7909 Intermediate Similarity NPC469496
0.7909 Intermediate Similarity NPC49451
0.7909 Intermediate Similarity NPC469454
0.79 Intermediate Similarity NPC477615
0.7885 Intermediate Similarity NPC115862
0.7885 Intermediate Similarity NPC97435
0.787 Intermediate Similarity NPC304495
0.7864 Intermediate Similarity NPC23364
0.7864 Intermediate Similarity NPC177680
0.7864 Intermediate Similarity NPC153776
0.7864 Intermediate Similarity NPC472729
0.7864 Intermediate Similarity NPC472730
0.7857 Intermediate Similarity NPC476706
0.7857 Intermediate Similarity NPC472934
0.7857 Intermediate Similarity NPC476707
0.7857 Intermediate Similarity NPC476708
0.785 Intermediate Similarity NPC144854
0.785 Intermediate Similarity NPC67321
0.785 Intermediate Similarity NPC3316
0.785 Intermediate Similarity NPC187435
0.785 Intermediate Similarity NPC293512
0.7843 Intermediate Similarity NPC471775
0.7838 Intermediate Similarity NPC473798
0.783 Intermediate Similarity NPC471293
0.783 Intermediate Similarity NPC65523
0.7818 Intermediate Similarity NPC236217
0.7818 Intermediate Similarity NPC474516
0.7818 Intermediate Similarity NPC152117
0.7818 Intermediate Similarity NPC472002
0.7818 Intermediate Similarity NPC234042
0.781 Intermediate Similarity NPC473928
0.78 Intermediate Similarity NPC184463
0.7798 Intermediate Similarity NPC474567
0.7798 Intermediate Similarity NPC235014
0.7798 Intermediate Similarity NPC210005
0.7798 Intermediate Similarity NPC473627
0.7788 Intermediate Similarity NPC106644
0.7788 Intermediate Similarity NPC17772
0.7788 Intermediate Similarity NPC241221
0.7778 Intermediate Similarity NPC151393
0.7778 Intermediate Similarity NPC306265
0.7778 Intermediate Similarity NPC473288
0.7778 Intermediate Similarity NPC168131
0.7778 Intermediate Similarity NPC477973
0.7778 Intermediate Similarity NPC258323
0.7768 Intermediate Similarity NPC152199
0.7768 Intermediate Similarity NPC134869
0.7768 Intermediate Similarity NPC207217
0.7768 Intermediate Similarity NPC235539
0.7767 Intermediate Similarity NPC472732
0.7767 Intermediate Similarity NPC472731
0.7757 Intermediate Similarity NPC477125
0.7757 Intermediate Similarity NPC181357
0.7757 Intermediate Similarity NPC253223
0.7757 Intermediate Similarity NPC472935
0.7748 Intermediate Similarity NPC255017
0.7748 Intermediate Similarity NPC471204
0.7745 Intermediate Similarity NPC36954
0.7745 Intermediate Similarity NPC183012
0.7745 Intermediate Similarity NPC108141
0.7736 Intermediate Similarity NPC472755
0.7736 Intermediate Similarity NPC8196
0.7736 Intermediate Similarity NPC475873
0.7736 Intermediate Similarity NPC239716
0.7736 Intermediate Similarity NPC270046
0.7736 Intermediate Similarity NPC4620
0.7736 Intermediate Similarity NPC264048
0.7736 Intermediate Similarity NPC478057
0.7736 Intermediate Similarity NPC99266
0.7732 Intermediate Similarity NPC329738
0.7727 Intermediate Similarity NPC188738
0.7727 Intermediate Similarity NPC324683
0.7727 Intermediate Similarity NPC304180
0.7727 Intermediate Similarity NPC179798
0.7723 Intermediate Similarity NPC476300
0.7719 Intermediate Similarity NPC472933
0.7719 Intermediate Similarity NPC470777
0.7714 Intermediate Similarity NPC476270
0.7706 Intermediate Similarity NPC41405
0.7706 Intermediate Similarity NPC475922
0.7706 Intermediate Similarity NPC310546
0.7699 Intermediate Similarity NPC97908
0.7699 Intermediate Similarity NPC474654
0.7699 Intermediate Similarity NPC470854
0.7699 Intermediate Similarity NPC122033
0.7699 Intermediate Similarity NPC287343
0.7692 Intermediate Similarity NPC216478
0.7692 Intermediate Similarity NPC70733
0.7692 Intermediate Similarity NPC56071
0.7685 Intermediate Similarity NPC59530
0.7685 Intermediate Similarity NPC230541
0.7685 Intermediate Similarity NPC143609
0.7684 Intermediate Similarity NPC327002
0.7679 Intermediate Similarity NPC474181
0.7679 Intermediate Similarity NPC18547
0.7679 Intermediate Similarity NPC474906
0.7679 Intermediate Similarity NPC472400
0.767 Intermediate Similarity NPC472734
0.767 Intermediate Similarity NPC472675
0.767 Intermediate Similarity NPC256230
0.767 Intermediate Similarity NPC21681
0.767 Intermediate Similarity NPC472733
0.7664 Intermediate Similarity NPC475676
0.7664 Intermediate Similarity NPC472748
0.7664 Intermediate Similarity NPC220964
0.7664 Intermediate Similarity NPC258532
0.7658 Intermediate Similarity NPC280782
0.7658 Intermediate Similarity NPC470063
0.7658 Intermediate Similarity NPC11252
0.7658 Intermediate Similarity NPC317687
0.7658 Intermediate Similarity NPC269530
0.7658 Intermediate Similarity NPC289312
0.7647 Intermediate Similarity NPC318332
0.7642 Intermediate Similarity NPC324017
0.7642 Intermediate Similarity NPC281702
0.7642 Intermediate Similarity NPC293753
0.7642 Intermediate Similarity NPC223834
0.7642 Intermediate Similarity NPC234892
0.7642 Intermediate Similarity NPC476081
0.7642 Intermediate Similarity NPC137430
0.7642 Intermediate Similarity NPC472754
0.7642 Intermediate Similarity NPC320019
0.7636 Intermediate Similarity NPC29133
0.7636 Intermediate Similarity NPC161816
0.7636 Intermediate Similarity NPC115257
0.7636 Intermediate Similarity NPC37116
0.7632 Intermediate Similarity NPC146280
0.7632 Intermediate Similarity NPC297179
0.7632 Intermediate Similarity NPC124676
0.7624 Intermediate Similarity NPC252433
0.7624 Intermediate Similarity NPC208839
0.7624 Intermediate Similarity NPC30515
0.7624 Intermediate Similarity NPC303697
0.7624 Intermediate Similarity NPC476705
0.7615 Intermediate Similarity NPC55972
0.7615 Intermediate Similarity NPC327286
0.7615 Intermediate Similarity NPC472439
0.7615 Intermediate Similarity NPC169888
0.7615 Intermediate Similarity NPC293850
0.7615 Intermediate Similarity NPC469916
0.7611 Intermediate Similarity NPC270478
0.7611 Intermediate Similarity NPC148458
0.76 Intermediate Similarity NPC269267
0.76 Intermediate Similarity NPC307411
0.76 Intermediate Similarity NPC5509
0.7596 Intermediate Similarity NPC111348

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC101067 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7549 Intermediate Similarity NPD6399 Phase 3
0.7524 Intermediate Similarity NPD5696 Approved
0.75 Intermediate Similarity NPD8297 Approved
0.7455 Intermediate Similarity NPD6686 Approved
0.7429 Intermediate Similarity NPD6083 Phase 2
0.7429 Intermediate Similarity NPD6084 Phase 2
0.7429 Intermediate Similarity NPD7902 Approved
0.7411 Intermediate Similarity NPD6650 Approved
0.7411 Intermediate Similarity NPD6649 Approved
0.7391 Intermediate Similarity NPD7115 Discovery
0.7387 Intermediate Similarity NPD6373 Approved
0.7387 Intermediate Similarity NPD6372 Approved
0.7364 Intermediate Similarity NPD6412 Phase 2
0.7364 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD4225 Approved
0.7353 Intermediate Similarity NPD6698 Approved
0.7353 Intermediate Similarity NPD46 Approved
0.7321 Intermediate Similarity NPD6371 Approved
0.7308 Intermediate Similarity NPD7748 Approved
0.7238 Intermediate Similarity NPD5210 Approved
0.7238 Intermediate Similarity NPD4629 Approved
0.7238 Intermediate Similarity NPD5695 Phase 3
0.7232 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD6319 Approved
0.7143 Intermediate Similarity NPD7900 Approved
0.7143 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6899 Approved
0.7143 Intermediate Similarity NPD5282 Discontinued
0.7143 Intermediate Similarity NPD6881 Approved
0.713 Intermediate Similarity NPD4632 Approved
0.7129 Intermediate Similarity NPD7521 Approved
0.7129 Intermediate Similarity NPD7334 Approved
0.7129 Intermediate Similarity NPD6684 Approved
0.7129 Intermediate Similarity NPD7146 Approved
0.7129 Intermediate Similarity NPD6409 Approved
0.7129 Intermediate Similarity NPD5330 Approved
0.7117 Intermediate Similarity NPD7128 Approved
0.7117 Intermediate Similarity NPD5739 Approved
0.7117 Intermediate Similarity NPD6675 Approved
0.7117 Intermediate Similarity NPD6402 Approved
0.7115 Intermediate Similarity NPD7515 Phase 2
0.7105 Intermediate Similarity NPD8130 Phase 1
0.7075 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD5697 Approved
0.7043 Intermediate Similarity NPD6882 Approved
0.7025 Intermediate Similarity NPD8328 Phase 3
0.7019 Intermediate Similarity NPD7838 Discovery
0.7018 Intermediate Similarity NPD7290 Approved
0.7018 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD7102 Approved
0.7018 Intermediate Similarity NPD6883 Approved
0.6991 Remote Similarity NPD7320 Approved
0.699 Remote Similarity NPD6672 Approved
0.699 Remote Similarity NPD5737 Approved
0.699 Remote Similarity NPD6903 Approved
0.699 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6967 Remote Similarity NPD7492 Approved
0.6964 Remote Similarity NPD6008 Approved
0.6961 Remote Similarity NPD3618 Phase 1
0.6957 Remote Similarity NPD6847 Approved
0.6957 Remote Similarity NPD6617 Approved
0.6957 Remote Similarity NPD6869 Approved
0.6952 Remote Similarity NPD6411 Approved
0.6952 Remote Similarity NPD7983 Approved
0.6935 Remote Similarity NPD7736 Approved
0.6931 Remote Similarity NPD4786 Approved
0.6931 Remote Similarity NPD3133 Approved
0.6931 Remote Similarity NPD3666 Approved
0.6931 Remote Similarity NPD3665 Phase 1
0.693 Remote Similarity NPD6012 Approved
0.693 Remote Similarity NPD6014 Approved
0.693 Remote Similarity NPD6013 Approved
0.693 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4753 Phase 2
0.6917 Remote Similarity NPD6054 Approved
0.6916 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6911 Remote Similarity NPD6616 Approved
0.6903 Remote Similarity NPD5701 Approved
0.69 Remote Similarity NPD3667 Approved
0.6887 Remote Similarity NPD5778 Approved
0.6887 Remote Similarity NPD5779 Approved
0.6881 Remote Similarity NPD7638 Approved
0.6881 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6863 Remote Similarity NPD1694 Approved
0.6857 Remote Similarity NPD5785 Approved
0.6855 Remote Similarity NPD8293 Discontinued
0.6855 Remote Similarity NPD7078 Approved
0.6842 Remote Similarity NPD6011 Approved
0.6818 Remote Similarity NPD7639 Approved
0.6818 Remote Similarity NPD7640 Approved
0.681 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6807 Remote Similarity NPD6009 Approved
0.6803 Remote Similarity NPD6370 Approved
0.68 Remote Similarity NPD5369 Approved
0.6792 Remote Similarity NPD5284 Approved
0.6792 Remote Similarity NPD6079 Approved
0.6792 Remote Similarity NPD5281 Approved
0.6777 Remote Similarity NPD6059 Approved
0.6772 Remote Similarity NPD7260 Phase 2
0.6762 Remote Similarity NPD6101 Approved
0.6762 Remote Similarity NPD6673 Approved
0.6762 Remote Similarity NPD5328 Approved
0.6762 Remote Similarity NPD6904 Approved
0.6762 Remote Similarity NPD6080 Approved
0.6762 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6754 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6752 Remote Similarity NPD6053 Discontinued
0.6748 Remote Similarity NPD7604 Phase 2
0.6733 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6724 Remote Similarity NPD4634 Approved
0.6721 Remote Similarity NPD6015 Approved
0.6721 Remote Similarity NPD5983 Phase 2
0.6721 Remote Similarity NPD6016 Approved
0.67 Remote Similarity NPD4695 Discontinued
0.6699 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6699 Remote Similarity NPD5363 Approved
0.6698 Remote Similarity NPD5207 Approved
0.6697 Remote Similarity NPD4697 Phase 3
0.6667 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5988 Approved
0.6667 Remote Similarity NPD5286 Approved
0.6667 Remote Similarity NPD4696 Approved
0.6667 Remote Similarity NPD5285 Approved
0.6667 Remote Similarity NPD8295 Clinical (unspecified phase)
0.664 Remote Similarity NPD7507 Approved
0.664 Remote Similarity NPD6336 Discontinued
0.6636 Remote Similarity NPD8035 Phase 2
0.6636 Remote Similarity NPD4755 Approved
0.6636 Remote Similarity NPD8034 Phase 2
0.6636 Remote Similarity NPD6050 Approved
0.6635 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6635 Remote Similarity NPD5279 Phase 3
0.6607 Remote Similarity NPD5344 Discontinued
0.6604 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6589 Remote Similarity NPD6845 Suspended
0.6585 Remote Similarity NPD8516 Approved
0.6585 Remote Similarity NPD8515 Approved
0.6585 Remote Similarity NPD8517 Approved
0.6585 Remote Similarity NPD8513 Phase 3
0.6583 Remote Similarity NPD6274 Approved
0.6574 Remote Similarity NPD4202 Approved
0.6571 Remote Similarity NPD3573 Approved
0.6571 Remote Similarity NPD7524 Approved
0.6569 Remote Similarity NPD4221 Approved
0.6569 Remote Similarity NPD4223 Phase 3
0.6569 Remote Similarity NPD6435 Approved
0.6557 Remote Similarity NPD7101 Approved
0.6557 Remote Similarity NPD7100 Approved
0.6555 Remote Similarity NPD8133 Approved
0.6552 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6549 Remote Similarity NPD5226 Approved
0.6549 Remote Similarity NPD5225 Approved
0.6549 Remote Similarity NPD5224 Approved
0.6549 Remote Similarity NPD5211 Phase 2
0.6549 Remote Similarity NPD4633 Approved
0.6545 Remote Similarity NPD5222 Approved
0.6545 Remote Similarity NPD7732 Phase 3
0.6545 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6545 Remote Similarity NPD5221 Approved
0.6545 Remote Similarity NPD7614 Phase 1
0.6542 Remote Similarity NPD5692 Phase 3
0.6538 Remote Similarity NPD5329 Approved
0.6518 Remote Similarity NPD4700 Approved
0.6514 Remote Similarity NPD6001 Approved
0.6509 Remote Similarity NPD5208 Approved
0.6505 Remote Similarity NPD7154 Phase 3
0.65 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6491 Remote Similarity NPD5175 Approved
0.6491 Remote Similarity NPD5174 Approved
0.6486 Remote Similarity NPD5173 Approved
0.6484 Remote Similarity NPD7319 Approved
0.6481 Remote Similarity NPD7637 Suspended
0.6481 Remote Similarity NPD5693 Phase 1
0.6481 Remote Similarity NPD5694 Approved
0.6476 Remote Similarity NPD5690 Phase 2
0.6476 Remote Similarity NPD5786 Approved
0.6476 Remote Similarity NPD6098 Approved
0.6475 Remote Similarity NPD6335 Approved
0.6466 Remote Similarity NPD6614 Approved
0.646 Remote Similarity NPD5223 Approved
0.6452 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6452 Remote Similarity NPD7503 Approved
0.6452 Remote Similarity NPD8033 Approved
0.6449 Remote Similarity NPD1695 Approved
0.6446 Remote Similarity NPD6868 Approved
0.6442 Remote Similarity NPD3668 Phase 3
0.6442 Remote Similarity NPD4197 Approved
0.6435 Remote Similarity NPD5141 Approved
0.641 Remote Similarity NPD4729 Approved
0.641 Remote Similarity NPD4730 Approved
0.6408 Remote Similarity NPD4269 Approved
0.6408 Remote Similarity NPD4270 Approved
0.6396 Remote Similarity NPD7839 Suspended
0.6393 Remote Similarity NPD6317 Approved
0.6379 Remote Similarity NPD4768 Approved
0.6379 Remote Similarity NPD4767 Approved
0.6373 Remote Similarity NPD5368 Approved
0.6373 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6371 Remote Similarity NPD8294 Approved
0.6371 Remote Similarity NPD8377 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data